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Disorders of the developing brain represent a major health problem. The neurological
manifestations of brain lesions can range from severe clinical deficits to more subtle
neurological signs or behavioral problems and learning disabilities, which often become
evident many years after the initial damage. These long-term sequelae are due at
least in part to central nervous system immaturity at the time of the insult. The
blood-brain barrier (BBB) protects the brain and maintains homeostasis. BBB alterations
are observed during both acute and chronic brain insults. After an insult, excitatory amino
acid neurotransmitters are released, causing reactive oxygen species (ROS)-dependent
changes in BBB permeability that allow immune cells to enter and stimulate an
inflammatory response. The cytokines, chemokines and other molecules released as well
as peripheral and local immune cells can activate an inflammatory cascade in the brain,
leading to secondary neurodegeneration that can continue for months or even years
and finally contribute to post-insult neuronal deficits. The role of the BBB in perinatal
disorders is poorly understood. The inflammatory response, which can be either acute
(e.g., perinatal stroke, traumatic brain injury) or chronic (e.g., perinatal infectious diseases)
actively modulates the pathophysiological processes underlying brain injury. We present
an overview of current knowledge about BBB dysfunction in the developing brain during
acute and chronic insults, along with clinical and experimental data.
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INTRODUCTION
The blood-brain barrier (BBB) is a physical barrier essential for
the maintenance of a precisely regulated intracerebral microen-
vironment. Its characteristics limit paracellular diffusion while
allowing the tightly controlled receptor-mediated endocytosis of
larger molecules and the transporter-mediated intake of smaller
nutrients like glucose, insulin and iron. Endothelial cells inter-
act closely with other central nervous system (CNS) cells such
as neurons, pericytes and astrocytes, through adherens junctions,
Abbreviations: BBB, blood-brain barrier; CAV, caveolin; Cld5, claudin-5; CNS,
central nervous system; GM-IVH, Intraventricular hemorrhage of the germinal
matrix; HIE, hypoxic-ischemic encephalopathy; HIF, hypoxia-inducible factor; IL,
interleukin; LPS, lipopolysaccharide; MMP, matrix metalloproteinase; NO, nitric
oxide; NOS, nitric oxide synthase; NVU, neurovascular unit; Occl, occluding; P,
postnatal day; ROS, reactive oxygen species; TBI, traumatic brain injury; TIMP,
tissue inhibitor of metalloproteinases; TJ, tight junction; TNF, tumor necrosis fac-
tor; VEGF, vascular endothelial growth factor; WMD, white-matter damage; ZO,
zonula occludens.
influx and efflux transporters, metabolic enzymes, the extracel-
lular matrix, astrocytic endfeet etc. All these structures together
constitute the Neurovascular Unit (NVU), and are believed to be
essential for the regulation of BBB permeability (Ballabh et al.,
2004).
For a long time, the BBB was considered “incomplete” dur-
ing fetal life. However, there is ample evidence to suggest that the
BBB is already well developed (Ballabh et al., 2005). For instance,
the formation of tight junctions (TJs) takes place at the same
time as angiogenesis (Virgintino et al., 2004), and even the first
vessels to invade the avascular neuroectoderm are impermeable
to albumin and immunoglobulins. Nevertheless, fetal brain ves-
sels exhibit different, and in some respects increased, transport
properties for amino acids and other metabolites, reflecting the
higher demand for nutrients in the developing CNS (Ek et al.,
2001, 2006; Johansson et al., 2006, 2008; Saunders et al., 2012).
Understanding the changes that occur in the BBB during nor-
mal development is critical, as it is not only a site of possible
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vulnerability to injury but also a potential therapeutic route for
injuries occurring during the perinatal period. Perinatal brain
damage is one of the leading causes of lifelong disability, includ-
ing cerebral palsy, seizure disorders, sensory impairment, and
cognitive limitations (Low, 2004). This brain damage could be
due to inflammatory, hypoxic-ischemic, hemorrhagic or excito-
toxic mechanisms, or a combination of these. The lifetime cost
of the care of one child affected by cerebral palsy is about 1
million US dollars (CDC CfDCaP, 2004), highlighting the need
to develop new strategies for treatment and prevention. The
only treatment with proven efficacy for perinatal brain injury is
hypothermia, but this can only be applied safely to term infants
with hypoxic-ischemic encephalopathy. Hypothermia in these
infants reduces brain injury, doubling the chances of survival
without clinical deficits (Edwards et al., 2010). However, more
efforts are needed to find novel neuroprotective treatments for
perinatal brain damage, especially in preterm infants. Designing
neuroprotective molecules requires a detailed knowledge of the
pathophysiology of brain damage, including BBB damage, in this
population. This will facilitate the delivery of neuroprotective
molecules, whose efficacy is strictly dependent on their capacity
to cross brain barriers.
Currently, translational research is increasingly focused on
the broader functional aspects of the brain response to injury,
shifting from cell-oriented studies to experimental research on
physiological concepts such as BBB integrity. This is due to the
fact that dysfunctions of the BBB, such as the impairment of
TJ formation/function, are a contributing factor in a number of
neurological diseases in adults and infants. In models of peri-
natal injuries in term infants, cerebrovascular endothelial cells
can be damaged by hypoxic-ischemic insults, an activated excito-
toxic cascade or traumatic brain injury, leading to impaired BBB
function. The link between BBB dysfunction and injury due to
the dysregulation of developmental processes, such as occurs to a
greater extent in preterm infants, is less well studied.
The aim of this review is to describe current understanding of
BBB dysfunction in the developing brain during the most com-
mon subtypes of injury, supported by clinical and experimental
data.
BASICS OF BBB DEVELOPMENT AND AGE-RELATED DIFFERENCES IN
FUNCTION
The specific barrier characteristics of BBB endothelial cells within
the developing CNS are induced during angiogenesis by complex
crosstalk with cellular and acellular elements. During develop-
ment, the CNS is vascularized by the angiogenic sprouting of
vascular networks from the surrounding mesoderm in a precise
spatiotemporal manner that differs among species. Which cell
type is responsible for BBB differentiation has not yet been clar-
ified: astrocytes have long been considered as the main source
of BBB-inducing signals, but barrier induction most likely takes
place well before astrocyte differentiation, so there is a proba-
ble influence of neuroblast cells or pericytes (Bauer and Bauer,
2000; Armulik et al., 2010; Daneman et al., 2010a). These different
structures and cells have different maturation rates across species
and across developmental stages, so animal models are not always
representative of the human situation in every respect.
With regard to the developmental changes in the BBB, the
presence of TJs in cerebral blood vessels and the expression of
influx and efflux transporters is even higher at mid-gestation than
in adulthood; for instance, TJs appear as early as 8 weeks of ges-
tation in humans, at 13 days in mice and at postnatal day (P) 5
in Monodelphis opossums, which is when the first vessels appear
in the neocortex (Ek et al., 2012). These TJ proteins are func-
tional, as recent ultrastructural studies have demonstrated that
the TJs of both endothelial cells in cerebral blood vessels and
choroidal epithelial cells in embryos and neonates restrict the pas-
sage of low-molecular-weight molecules (Ek et al., 2003, 2006;
Johansson et al., 2006). However, as these blood vessels do not
display the properties of mature vessels with respect to pericyte
coverage or junctional organization, it is probable that their BBB
properties are not yet fully mature. This has been confirmed in
part by a recent study showing that several hundreds of genes are
differentially expressed between early postnatal and adult brain
endothelial cells, indicating differences in molecular and proba-
bly physiological properties (Daneman et al., 2010b). However,
the implication of these differences in the BBB across develop-
mental stages for brain health remains unknown (Engelhardt and
Liebner, 2014).
PRINCIPAL INSULTS TO THE DEVELOPING BRAIN AND
THEIR ANIMAL MODELS
GERMINAL MATRIX HEMORRHAGE
Intraventricular hemorrhage of the germinal matrix (GM-IVH)
causes very substantial and permanent injury, and is the leading
cause of hydrocephalus in children. GM-IVH occurs when a hem-
orrhage in the GM breaks through the ependyma and into the
lateral ventricles (see Figure 1). About 12,000 premature infants
develop IVH every year in the United States alone (Vohr et al.,
1999; Ballabh, 2010), with the incidence in extremely premature
infants being approximately 45% (Wilson-Costello et al., 2005).
Infants with a history of IVH have a higher incidence of seizures,
neurodevelopmental delays, cerebral palsy and death. The inci-
dence of IVH in very low birth weight infants (<1500 g) declined
from 40% in the early 1980s to 20% in the late 1980s (Philip
et al., 1989). However, because of the sharply increased survival
of extremely premature infants, in the last two decades, the inci-
dence of IVH has remained stable (Jain et al., 2009). Thus, IVH
continues to be one of the major problems faced by prema-
ture infants in modern neonatal intensive care units worldwide.
The etiopathogenesis of GM hemorrhage is multifactorial, with
a combination of vascular and intravascular factors considered
to be responsible. It is necessary to understand the reason for
the vulnerability of GM microvessels to hemorrhage in order to
develop therapeutic strategies.
GM-IVH has beenmodeled in several animal species including
the dog, rabbit, sheep, rat, mouse and pig, either by directly inject-
ing blood into the ventricles or by changing hemodynamic prop-
erties, such as blood pressure, the volume of blood circulating,
serum glycerol, carbon dioxide, osmolarity or oxygenation lev-
els (Goddard et al., 1980; Yoshioka et al., 1989; Balasubramaniam
and Del Bigio, 2006; Georgiadis et al., 2008; Tosun et al., 2013).
The two most-used animals models of IVH are the intracere-
bral injection of sterile collagenase, a hemorrhage-inducing agent
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FIGURE 1 | (A) Modified by J. Volpe, Lancet Neurology 2009. (A1) Cystic
Periventricular Leucomalacia (PVL) and Diffuse White Matter Injury (DWMI)
and (A2) germinal matrix haemorrage-intraventricular Haemorrage (GMH-IVH)
and GMH-IVH with periventricular Haemorrage infarction (PHI). Schematic
coronal sections from the brain of a 28-week-old premature infant. Color key:
Focal necrotic lesions in cystic PVL (small circles), focal necrotic lesions in
DWMI (black dots), diffuse cellular changes in both cystic PVL and DWMI
(pink), hemorrhage into ganglionic eminence (red) that results in IVH in the
ependymal (left) or PHI (right). (B,B1) T1 weighted image illustrating an acute
right ischemic stroke is a sickle cell disease children previously affected by a
left ischemic stroke. (B2) Brain diffusion-weighted imaging (DWI) sequence
of the same patient. (B3,B4) a 3D time-of-flight magnetic resonance
angiography (MRA) suggesting dissection of the left internal carotid (B2:
coronal view, B3 transverse view).
(Krafft et al., 2012; Lekic et al., 2012), in mice, and the intrac-
erebroventricular injection of fresh homologs blood in adult
Sprague-Dawley rats or in piglets at 9–22 h of life (Aquilina et al.,
2007, 2012). The appropriate model is selected based on the
pathophysiology of hemorrhage induction and injury progres-
sion. The blood injection model mimics a rapidly progressing
hemorrhage, whereas collagenase enzymatically disrupts the basal
lamina of brain capillaries, causing an active bleed that generally
evolves over several hours. The effects of GM-IVH on the BBB
have not been extensively assessed in any of these models.
WHITE MATTER DAMAGE
Whitematter damage (WMD) is a characteristic injury of preterm
infants, involving destructive microcystic lesions within the
white matter, the disrupted maturation of oligodendrocytes and
hypomyelination (Degos et al., 2010a) (see Figure 1). Although
WMD is also observed in term infants, the relative contributions
of direct injury to oligodendrocytes/myelin and secondary injury
due to gray matter damage are still being defined. WMD is a
healthcare priority, as it is the main cause of neurological hand-
icap in preterm infants and the principal cause of cerebral palsy
(Tahraoui et al., 2001). On a pathophysiological level, based on
strong clinical evidence and a wealth of studies in animal models,
the hypothesis of a purely hypoxic-ischemic cause of injury has
been replaced by a multifactorial hypothesis. The central role of
inflammation is now appreciated, given its contribution in terms
of excess cytokines, free radicals, increased excitatory amino acid
release (excitotoxicity), and trophic factor imbalance (Lipton and
Rosenberg, 1994; Evrard et al., 1997; Yoon et al., 1997; Back et al.,
1998). Clinical spectroscopy data do support a role for hypoxia-
ischemia in the pathophysiology of WMD, but it is increasingly
evident that inflammation-induced endothelial cell dysfunction
and changes in glial metabolism may contribute substantially to
these effects (Schuhmann et al., 2003; Lodygensky et al., 2014).
The multifactorial hypothesis includes the concept of sensitiza-
tion, whereby vulnerability to hypoxia-ischemia or excitotoxicity
is enhanced by the preexistence of inflammation (Hagberg and
Mallard, 2005; Favrais et al., 2007, 2011), which in the clinical
setting is reported to occur in at least 40% of preterm infants.
Experimental paradigms that have addressed the pathophysi-
ology of WMD include models in the mouse, rat and sheep using
inflammation, excitotoxicity and hypoxia-ischemia (Tahraoui
et al., 2001) (see Table 1). A well-characterized murine model
of perinatal excitotoxic-induced WMD consists of the i.c. injec-
tion of the glutamate analog ibotenate, a potent neurotoxin that
activates the N-methyl-D-aspartate receptor, in 5-day-old mouse
pups (Marret et al., 1995). Ibotenate is commonly used to induce
brain lesions in both the hippocampus and the white matter, in
which it stimulates these receptors present on oligodendrocytes
and microglia (Degos et al., 2010b), leading to microcysts similar
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Table 1 | Some of the principal animal models mentioned in this review with correlate references.
Human pathologic condition Animal used and age of the animal Type of damage “inflicted” References
GMH-IVH Rabbit 29 day-gestation Glycerol administration 3 h
post-delivery
Ballabh et al., 2005
Dog (terme beagle pups) Phenilephrine hydrocloride i.v.
injection
Baud et al., 2004
Sprague-Dawley Rat P7 Intracerebral injection of
glibenclamide
Bauer and Bauer, 2000
Pregnant Wistar Dam Intrauterine injection of glibenclamide Bednarek et al., 2012
CD-1 mice Intrastriatal double injection of
autologous whole blood, Intrastriatal
injection of bacterial collagenase
Biran et al., 2008
Piglet i.c.v. injection of fresh homologs blood Bolton et al., 1998; Blond
et al., 2002
Diffuse white matter injury Cat pregnant LPS injections Briones et al., 2011
Rabbit pregnant E. coli injections Briones et al., 2011
Dog (beagle) P14 Bilateral carotid occlusion Briones et al., 2011
Swiss Mouse P5 Interacerebral ibotenate injections Briones et al., 2011
Long Evans Mouse P7 Unilateral carotid ligation+ hypoxia
H-I P7 Wistar rats Permanent occlusion of the Middle
Cerebral Artery (MCA), pMCAo + O2
8%
Evrard et al., 1997
Rice’s model adapted to other rat’s
ages
“ Favrais et al., 2007, 2011
Mouse P7 Blockade of the past External Carotid
Artery-Internal Carotid Artery
(ECA-ICA) bifurcation
Feng et al., 2008
External-internal carotid artery Favrais et al., 2011
Mouse P8 Permanent occlusion of the Middle
Cerebral Artery (MCA), pMCAo + O2
8%
Feng et al., 2008
Mouse P10 “ Feng et al., 2008
Mouse P12 “ Feng et al., 2008
Stroke Wistar Rat P7 pMCAo +bilateral transient Common
Carotid Artery (tCCAo) occlusion
Feng et al., 2008
Wistar Rat P10 “ Feng et al., 2008
CB17 mouse P12 pMCAO Favrais et al., 2011
TBI
Fluid percussion injury (FPI) models
Middle Rat Fluid-percussion brain injury of graded
severity
Labus et al., 2014
Cat
Rabbit
Fluid-percussion injury (3.5 atm.)
Pressure wave produced by a
fluid-percussion device
Labus et al., 2014
Sheep
Dog
Labus et al., 2014
Lateral Rat Fluid-percussion brain injury of graded
severity
Labus et al., 2014
C57BL/6 Mouse Right-sided parasagittal FPI Labus et al., 2014
Newborn pig Lateral FPI moderate severity (1.9–2.1
atm)
Labus et al., 2014
(Continued)
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Table 1 | Continued
Human pathologic condition Animal used and age of the animal Type of dommage “inflicted” References
Weight-drop models Rat Impact injuries in the hindpaw cortical
area segmented brass weight
free-falling through a Plexiglas guide
tube free-falling weight with a final
impact of 0.01 J
Labus et al., 2014
Rat adult Labus et al., 2014
C57BL/6 Mouse (10–16 weeks) Labus et al., 2014
Controlled cortical impact injury
Models
Ferret stroke-constrained pneumatic
impactor varying magnitudes of
controlled cortical impact
Labus et al., 2014
Mouse pneumatic impactor Labus et al., 2014
Rat CCI of velocity 3.5m/s and dwell time
400ms CCI + hypothermia
Labus et al., 2014
Yorkshire Swine Labus et al., 2014
Monkey Labus et al., 2014
Cat Cerebral wound made with a steel
sphere with a velocity of 240–300m/s
(0.9–1.4 J)
Labus et al., 2014
Penetrating Ballistic-like injury model Sprague-Dawley rats Simulated ballistic wound to the right
frontal hemisphere implemented by
an inflatable penetrating probe
Labus et al., 2014
C57Bl/6 Mouse pregnant (15 days of
gestation)
LPS intrauterine injections Labus et al., 2014
to those seen on post-mortem examination in preterm infants
(Verney et al., 2012). In this model, vulnerability to WMD is
increased by systemic inflammation (Dommergues et al., 2003;
Favrais et al., 2007; Aden et al., 2010), and the BBB is slightly
affected.
Animal models of preterm brain injury have also conclusively
shown that exposure to inflammation alone, even at low levels, is
sufficient to induce WMD similar to that seen clinically (Rousset
et al., 2006; Bednarek et al., 2012). In addition toWMD, the expo-
sure of fetal sheep to low-dose endotoxin leads to increased BBB
permeability, as assessed by staining for plasma albumin extrava-
sation (Yan et al., 2004). This effect has been noted in the cortical
white and gray matter and the thalamus, but not the cerebel-
lum. WMD comparable to that seen in preterm infants can also
be induced in the mouse or rat brain by the Vannucci hypoxia-
ischemia method at P3 or P5 or by chronic exposure to hypoxia
(P3–P11) (Hagberg et al., 2002). There is very little information
regarding the BBB in these models of preterm WMD.
HYPOXIC-ISCHEMIC ENCEPHALOPATHY
Hypoxic-ischemic encephalopathy (HIE) is considered a major
cause of brain injury in term neonates. At present, there are no
specific serum biomarkers or other tools to easily assess neurolog-
ical injury at birth, either in terms of its severity or the prediction
of neurodevelopmental outcome. Because of this knowledge gap,
all newborns with moderate or severe encephalopathy are treated
with hypothermia in an identical fashion. Randomized controlled
trials of therapeutic hypothermia have demonstrated a reduction
in death or severe disability at 18 months, but death and dis-
ability continue to occur in 30–70% of infants with severe to
moderate HIE despite cooling therapy (Shankaran et al., 2005;
Azzopardi et al., 2009; Tagin et al., 2012). The criteria used to
identify neonates with so-called HIE are (1) a pH ≤ 7 or base
deficit ≥16mEq/L in umbilical cord arterial plasma, and (2) a
history of an acute perinatal event or non-availability of arte-
rial blood gas or a pH or base deficit in the borderline range
associated with a 10-min APGAR score ≤5 or assisted ventila-
tion at birth. An understanding of the neuropathological pro-
cess that leads to HIE could lead to the identification of new
markers of neuronal injury that correlate with disease and neu-
rodevelopmental outcome, and thus facilitate a more targeted
therapeutic approach using adjunctive therapies (Chalak et al.,
2014).
To study the effects of oxygen and nutrient deprivation on the
developing brain, the species most commonly used are sheep,
rabbits, piglets and, most of all, rodents. Differences in tem-
poral phases of development between human and animal brain
structures make the choice of a specific species and the deter-
mination of a precise correlation between developmental stages
in the animal model and the corresponding stage in neonatal
brain development very complex. Based on several experimental
studies evaluating the developmental profile of the main neural
cells of interest, the scientific community has established that a
reasonable comparison can be drawn between P3/5 rodents and
preterm infants, and P7/10 rodents and term infants (Kinney and
Volpe, 2012).
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Across the wide range of species used to model HIE, the rela-
tive contribution of vessels supplying blood to the brain is variable
(Purves, 1972). In rodents, brain ischemia induced by the occlu-
sion of a single carotid artery is not always consistent, and injury
is typically induced by combining this with systemic hypoten-
sion. This combination of insults in the P7 rat, known as the
Rice-Vannucci model, was originally developed in 1981 and is
considered the pioneering model of HIE (Rice et al., 1981). It
has since been adapted to many postnatal ages and transferred to
the mouse (Derugin et al., 1998; Sheldon et al., 1998; Ohshima
et al., 2012; Tsuji et al., 2013). The brain’s response to global
hypoxia-ischemia is a multistep process. Within the first few
hours, regionally specific increases of cerebral blood flow occur
followed by decreases due to regional vasoconstriction or the
collapse of cardiac output, with the subsequent onset of exci-
totoxicity, energy depletion and the generation of free radicals,
leading to apoptotic and necrotic cell death and the generation
of edema (Ferrari et al., 2010a). This phase is followed within a
few hours/days by a second phase consisting of a neuroinflamma-
tory response, mitochondrial permeabilization, reperfusion and
loss of cerebral autoregulation, and the production of free rad-
icals (Hamrick and Ferriero, 2003; McLean and Ferriero, 2004).
Recent hypotheses describe a tertiary phase that occurs days or
even years after the injury and that contributes to the persistence
of inflammation and reduced efficacy of brain repair (Fleiss and
Gressens, 2012).
The effects of hypoxia-ischemia on the adult BBB include
the disruption of TJ proteins (in particular claudin-5 (Cld5),
occludin (Occl), zonula occludens (ZO) -1 and -2 (Bolton et al.,
1998; Fischer et al., 2002; Mark and Davis, 2002; Witt et al., 2003;
Sandoval and Witt, 2008; Zehendner et al., 2013) and increased
BBB permeability in in vitro studies (Fischer et al., 2000; Zhang
et al., 2000; Mark and Davis, 2002). These events are mediated by
proinflammatory cytokines such as tumor necrosis factor (TNF)
α, interleukin (IL)-1β, IL-8, monocyte chemoattractant protein-
1, intercellular adhesion molecule-1, vascular endothelial growth
factor (VEGF) and nitric oxide (NO), and astrocytes seems to play
a protective role (for a review, see Ballabh et al., 2004). However,
differences between the mature and developing brain limit the
possibility of extrapolating data from adult studies to neonates.
Concerning developmental age, there are few comparative
studies between barriers in the adult and developing brain in this
specific model, and the results are not always concordant; in fact,
studies in sheep show that the BBB becomes less susceptible to
hyperosmolar stress with age (Stonestreet et al., 2006), and in
rodents, it seems to be more vulnerable to hypoxia-ischemia at
early stages of development (Muramatsu et al., 1997). Studies in
rodent models of neonatal hypoxia-ischemia have indicated that
the integrity of brain barriers is compromised (Muramatsu et al.,
1997; Ferrari et al., 2010b; Tu et al., 2011; Yang et al., 2013a), a
finding confirmed by a study of cerebrospinal fluid (CSF) samples
from HIE infants showing that the ratio of the albumin concen-
tration in the CSF to that in the plasma is 5 times higher than
normal, suggesting leaky brain barriers in these infants (Kumar
et al., 2008). Most of these studies, however, precede more recent
knowledge of BBB characteristics suggesting that the BBB is more
resistant during the developmental period than after maturation
(Johansson et al., 2008; Ek et al., 2012; Saunders et al., 2012).
Additionally, these early studies did not examine specific TJ dis-
ruptions or undertake a qualitative evaluation of the passage of
substance and molecules, assessing only immunoglobulin (Ig) G
labeling at different time points. Further investigations are needed
to better understand BBB behavior in this model.
STROKE
Ischemic stroke occurs when cerebral blood flow is locally inter-
rupted due to a clot within a vessel (Davis and Donnan, 2012)
(see Figure 1). Perinatal stroke is defined as a cerebrovascular
event that occurs between 28 weeks of gestation and a postna-
tal age of 28 days. Its incidence is similar to that in the elderly,
approximately 1 in 4000 live births (Lynch et al., 2002), and it
is associated with cerebral palsy [which is correlated with infarct
size (Lee et al., 2005)], epilepsy, language delays and behavioral
abnormalities. Classically associated with hypoxia, recent animal
models have used permanent middle cerebral artery occlusion
in association with transient bilateral common carotid artery
occlusion to mimic an isolated acute ischemic event followed
by reperfusion on resuscitation. Currently, more reproducible
models are the 1998 Renolleau model in P7 Wistar rats and the
2013 Tsuji model in P9 CB-17 mice (Charriaut-Marlangue et al.,
2013). After stroke in adults, BBB leakage/disruption can occur
either transiently, in two distinct phases (Belayev et al., 1996;
Rosenberg et al., 1998), or continuously (McColl et al., 2008;
Kuntz et al., 2014). Although the basic mechanisms of neurode-
generation after stroke are shared across age groups, immaturity
critically affects brain susceptibility and response to ischemia-
related insults, includingmodes of neuronal death, inflammation,
leukocyte-mediated injury and susceptibility to reactive oxygen
species (ROS) (Benjelloun et al., 1999).
TRAUMATIC BRAIN INJURY
Traumatic Brain Injury (TBI) in children can cause more severe
cognitive and behavioral deficits than comparable injuries in
mature brains, and is one of the most common reasons for the
development of significant lifelong disability in a child (Anderson
et al., 2005; Rivara et al., 2012; Stanley et al., 2012; Roozenbeek
et al., 2013). This is particularly important if we consider that chil-
dren under the age of 4 years more frequently undergo TBI than
any other age group (Koepsell et al., 2011) and that injured infants
under the age of 12 months are at high risk of requiring intensive
care support (Keenan et al., 2003). A similar developmental sen-
sitivity to TBI can be seen in a rodent model of TBI, in which TBI
inflicted at P7 causes the maximum damage. In addition, during
the first 3 weeks of life, rodents display high sensitivity to excito-
toxicity, as seen during the developmental period in human brains
(i.e., maximal brain growth, synaptogenesis, and myelination).
Thus, P7 is considered the period of maximal sensitivity and the
best age to evaluate effects of TBI in rodents (Bittigau et al., 1999).
TBI can be simulated in different ways in various animal mod-
els: in the 1980s, a variety of species including cats, dogs, pigs and
non-human primates were used (Xiong et al., 2013), but since the
1990s the use of rodents has predominated thanks to the ease with
which experiments can be carried out and managed, and the lim-
ited costs. In addition, the ability to genetically modify mice has
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confirmed their position as the most-used species in laboratory
research (Longhi et al., 2001; Duhaime, 2006). Models of focal
TBI are the most common, induced by the impact of an object
on the head (contusion) or the sudden arrest of the head during
motion (deceleration) not necessarily requiring contact with an
object. The most common modes of contusion trauma induction
are lateral fluid percussion injury (Thompson et al., 2005), con-
trolled cortical impact injury (Dixon et al., 1991; Cernak, 2005;
Ajao et al., 2012; Pop et al., 2013) and focal TBI through a closed
skull (Chen et al., 1996). The primary injury process in TBI is
mechanical damage (vascular damage and bleeding caused by
shear forces), immediately followed by mast cell degranulation
(Stokely andOrr, 2008), and a secondary pathological phase char-
acterized by excitotoxicity, ischemia, mitochondrial dysfunction
and apoptosis (Xiong et al., 2013). This phase leads to the activa-
tion of inflammatory processes, which are themselves neurotoxic
(Hagberg et al., 2012) and mediated by immune cells resident in
the brain as well as by the transmigration of systemic immune
cells and BBB disruption (Ramlackhansingh et al., 2011).
An electronmicroscopic analysis of rat cerebral slices in an ani-
mal model of TBI (Dietrich et al., 1994) has revealed the presence
of microscopic hemorrhagic contusions or petechia, especially
in the white-gray matter interface underlying the somatosensory
cortex and cisterna ambiens, demonstrating that primary shear-
stress-induced vascular damage can be found distant from the ini-
tial injury site, indicating protein leakage and the extravasation of
blood cells. The choroid plexus is also activated by TBI inflicted at
a distance from the ventricles, leading not to blood-cerebrospinal
fluid barrier disruption but to the homing of choroidal mono-
cytes and neutrophils and the synthesis and secretion into the
CSF of inflammatory chemokines (Szmydynger-Chodobska et al.,
2009, 2012).
ROLE OF THE BBB IN THE PATHOPHYSIOLOGY OF
DEVELOPMENTAL BRAIN INSULTS
It would be difficult to thoroughly analyze in this review the large
amount of information available concerning the possible mecha-
nisms that influence BBB disruption in the developing brain. We
will therefore focus on a few selected factors.
EXCITOTOXICITY AND FREE RADICALS
NO is a weak free radical produced by the action of nitric oxide
synthase (NOS). The direct effects of this molecule on the BBB
during development have not been studied so far. However,
studies in adult rats demonstrate that in a model of stress-
induced neurodegeneration, the production of NO and related
oxidative-nitrosative compounds via the expression of inducible
NOS (iNOS) correlates with BBB disruption, as evaluated by
[14C]-sucrose uptake by brain tissue. The injection of the specific
iNOS inhibitor 1400 W prevents this increase in BBB perme-
ability. Since the developing brain is considered to be extremely
vulnerable to free radical damage due to its high lipid content
(O’Brien and Sampson, 1965), relatively high oxygen consump-
tion and capacity for ROS generation, and low concentrations of
the main antioxidant enzymes (Baud et al., 2004; Vannucci and
Hagberg, 2004; Miller et al., 2012), a potential role of this free
radical could be suspected.
Following neonatal hypoxia-ischemia, both neuronal (n) NOS
and endothelial (e) NOS are up-regulated, but while nNOS
knockout mice seem to be protected following neonatal hypoxia-
ischemia (Ferriero et al., 1996), studies indicate that eNOS can
play a neuroprotective role in the adult brain by influencing
neural migration and outgrowth and acting as a downstream reg-
ulator of angiogenesis (Huang et al., 1996). Further studies are
needed to clarify the different roles of specific NOS isoforms and
their link with BBB disruption.
Concerning white matter insults, in the presence of an acti-
vated excitotoxic cascade, damage to cerebrovascular endothelial
cells should cause alterations in BBB function that could exac-
erbate neuronal injury and death. Glutamic acid or glutamate
the most important excitatory neurotransmitter in the CNS, also
acts in the pathophysiology of neuronal damage. Excess gluta-
mate is known to induce neuronal death through a process in
which the overactivation of ionotropic and metabotropic gluta-
mate receptors triggers several intracellular signaling pathways,
leading to apoptosis, necrosis or both (Gudino-Cabrera et al.,
2014). Glutamate agonists, such as ibotenate, are frequently used
to reproduce excitotoxic insults in the CNS. However, there are,
to our knowledge, no studies that directly evaluate the effects of
excitotoxic insults on BBB permeability during development.
The pathophysiology of TBI can also be explained in part
by free radical formation and the effects of these on the BBB.
During TBI, the transmigration of circulating immune cells and
local microglial activation leads to the production of NO, ROS
and inflammatory mediators that are capable of interfering with
the BBB (Perez-Asensio et al., 2005; Briones et al., 2011). For
instance, the ROS-induced peroxidation of polyunsaturated fatty
acids in cell membranes gives rise to active aldehydes, signifi-
cantly increasing endothelial monolayer permeability in exper-
imental studies (Chodobski et al., 2011). In addition, oxidative
stress is associated with the endogenous antioxidant glutathione
and the increased permeability of the BBB, although only to
low-molecular-weight markers (Agarwal and Shukla, 1999), and
hydrogen peroxide has been demonstrated to increase BBB per-
meability via the Extracellular-signal-regulated Kinase (ERK) sig-
nal transduction pathway, along with the redistribution of Occl
and ZO-1 and -2 (Fischer et al., 2005).
ALTERATIONS OF THE BASAL LAMINA AND ENDOTHELIAL CELLS
One class of enzymes extensively studied for its role in the
BBB is family of proteases known as the matrix metallopro-
teinases (MMPs). TheMMPs cleave their protein substrates based
on a conserved mechanism that involves the interaction of an
active-site-bound water molecule with a Zn2+ ion. The MMPs
participate not only in pathophysiological processes but also in
many normal biological processes such as embryonic (including
brain) development, organ morphogenesis, blastocyst implanta-
tion, bone remodeling and wound healing (Brew et al., 2000).
Because of this dual nature of the MMPs, it would be interest-
ing to uncover their role in the developing brain after neonatal
hypoxia-ischemia and, more importantly, their long-term role
in neurological function. MMPs disrupt the BBB by degrading
TJ and basal lamina proteins, thereby leading to BBB leak-
age, leukocyte infiltration, brain edema and hemorrhage (Liu
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et al., 2012). The activity of the MMPs is regulated by a group
of endogenous proteins called tissue inhibitors of metallopro-
teinases (TIMPs), which bind to active and alternative sites of
activated MMPs.
MMPs have been implicated in cerebral ischemia, and sev-
eral studies have revealed that plasma MMP-9 concentrations
strongly correlate with stroke severity in patients and that MMP-
9 inhibition attenuates early BBB disruption and cerebral edema
while promoting the expression of TJ proteins and angiogen-
esis (Rosenberg et al., 1998; Liu et al., 2009; Gu et al., 2012;
Yang et al., 2013b). For instance, in a mouse model of focal
cerebral ischemia, the deletion of the TIMP-1 gene results in
increased MMP-9 protein expression and gelatinolytic activity,
and is accompanied by exacerbated BBB disruption, neuronal
apoptosis and ischemic injury when compared to wild-type ani-
mals (Fujimoto et al., 2008). Correspondingly, BBB leakage is
reduced by TIMP-1 overexpression, and 24 h infarct volumes are
also reduced (Maier et al., 2006). MMP-9 has been shown to
degrade TJ proteins (Cld-5, Occl, ZO-1) in animal models of
focal cerebral ischemia (Yang and Rosenberg, 2011). Aberrant
MMP-9 proteolytic activity degrades not only TJ proteins but also
basal membrane proteins (e.g., fibronectin, laminin, collagen, and
others). This degradation is associated with an increase in BBB
permeability, resulting in brain infarction, edema and hyperten-
sion in both animal models (Lee et al., 2007; Rosenberg and Yang,
2007; Yang et al., 2007) and human patients (Gasche et al., 2001;
Castellanos et al., 2003; Lo, 2008). In a study conducted in P7
rat pups, hypoxia-ischemia was induced by unilateral ligation
of the right carotid artery followed by hypoxia, and a broad-
spectrum MMP inhibitor was injected intraperitoneally (i.p.).
This early MMP inhibition provided both acute and long-term
neuroprotection by reducing TJ protein degradation, preserving
BBB integrity and reducing brain edema after neonatal hypoxic-
ischemic injury (Chen et al., 2009). In addition, IgG accumulation
in the brain is reduced in neonatal MMP-9 knockout (KO) mice
compared to wild-type mice 24 h after hypoxia-ischemia (Svedin
et al., 2007; Vexler and Yenari, 2009), suggesting that MMP-9 con-
tributes to the opening of the BBB shortly after hypoxia-ischemia.
However, there are still several points that need to be clarified.
Like many biological mediators, MMPs can be used for good
or bad, and this seems to be the case in the brain too. In fact,
although MMPs seem to be involved in damage early after stroke,
other studies demonstrate that they take on another role later in
the process, contributing to repair (Stolp et al., 2005). However,
it has been noted that exogenous MMPs kill neurons in culture
(Stonestreet et al., 2006; Stolp et al., 2011). This could be due to
temporal variations in the action of MMP-9 and/or to the diver-
gent functions of different subtypes of MMPs. These aspects are
well reviewed in Lakhan et al. (2013). Briefly, whereas MMP-2
could play a role in the initial opening of the BBB, MMP-9 seems
to be more important for the secondary, delayed, opening of the
BBB after ischemia, which is necessary for vascular angiogenesis
and neuronal regeneration.
A possible explanation for the action of the MMPs is media-
tion by caveolin-1 (Cav-1). ROS can stimulate MMP activation
through the loss of caveolin-1, a protein encoded by the cav1
gene and a critical determinant of BBB permeability (Gu et al.,
2011). Recent studies have revealed that Cav-1 can prevent the
degradation of TJ proteins and protect BBB integrity by inhibit-
ing the production of reactive nitrogen species (RNS) and MMP
activity. In addition, Cav-1 KO mice show higher rates of apop-
totic cell death and larger infarct volumes than wild- in ischemic
brains, and the production of NO induces the loss of Cav-1 in
focal cerebral ischemia and reperfusion injury. The downregu-
lation of Cav-1 is correlated with an increase in the activity of
MMP-2 and -9, decreased ZO-1 expression and increased BBB
permeability (Gu et al., 2012).
ANGIOGENESIS
Although hypoxia-induced angiogenesis is considered beneficial
since it allows more oxygen delivery to ischemic regions, there
are some associated aspects that are not necessarily positive. One
of these aspects is BBB permeability. The main molecules impli-
cated in this process of endothelial cell regression and regrowth
are VEGF, placental growth factor, acidic fibroblast growth fac-
tor (FGF), TNFα, IL-8 and erythropoietin. The VEGF family
has six homologs members, of which the most widely studied
is VEGF-A, and 3 tyrosine kinase receptors. Of these, VEGF
receptors -1 and -2, which bind VEGF-A, are involved in blood
vessel growth, endothelial cell mitogenesis and vasodilatation
(via NO-dependent pathways). VEGF is thus a key regulator of
vasculogenesis, and endothelial cells that express VEGF also pro-
duce MMPs and plasminogen activators to initiate extracellular
matrix degradation, the first step in angiogenesis. In response to
hypoxia, hypoxia-inducible factor (HIF) -1 is stabilized, leading
to the augmented expression of the angiogenic genes mentioned
above (Semenza, 2010). Three HIF isoforms are known (HIF-1α,
HIF-2α, and HIF-3α), of which HIF-2α is restricted to vascular
endothelial cells (Skuli et al., 2009). It has been suggested that in
endothelial cells, HIF-1α plays a role in metabolism, proliferation
and survival, while HIF-2α is involved in cell migration, adhesion
and vascular integrity. Following hypoxia in the neonatal brain,
HIF-1α starts to accumulate in neurons, an effect that has been
shown to be protective and antiapoptotic (Tahraoui et al., 2001;
Tagin et al., 2012). However, in a study evaluating the role of
HIF-1α in BBB permeability in a rat subarachnoid hemorrhage
model, the elevated expression of HIF-1α in brain tissues tempo-
rally coincided with brain edema formation and BBB disruption.
In addition, BBB disruption, as determined by the extravasation
of Evans Blue (a standard ink tracer used in the CNS), was down-
regulated by the inhibition of either HIF-1α or MMP-9. In the
present study, the inhibition of HIF-1α reduced not only brain
edema, but also the expression of aquaporin-4 (see Section on
“Edema”) and MMP-9, suggesting that HIF-1α may be a key
protein in brain edema formation and BBB disruption, possibly
through aquaporin-4 and MMP-9 regulation (Tcharmtchi et al.,
2000). Whether the induction of HIF-1α is beneficial or harm-
ful is thus still debatable. Some recent studies have reported that
HIF-1α and its target genes may contribute to cell death, tis-
sue destruction and the formation of brain edema, primarily in
the acute phase after ischemic brain damage (Thibeault et al.,
2001; Thompson et al., 2005). Therefore, inhibiting this molecule
immediately following damage could be effective in improving
neurological outcome by protecting the brain from secondary
Frontiers in Neuroscience | Neurogenomics February 2015 | Volume 9 | Article 40 | 8
Moretti et al. Barrier disfunction of neurodeveloping disorders
injury following edema and BBB disruption (Tcharmtchi et al.,
2000).
VEGF also appears to have a dual response to hypoxia-
ischemia depending on the time frame studied. Several studies
conducted both in adults and, to a lesser extent, in the neona-
tal brain following hypoxia, show that the i.c. injection of VEGF
results in reduced brain injury, with the reduction of brain edema
and infarct volume, a decrease in apoptotic cells and BBB per-
meability (Kaya et al., 2005; Feng et al., 2008). In addition, the
inhibition of VEGF receptor-2 decreases endothelial cell prolifer-
ation, increases cell death and worsens stroke injury in a neonatal
rodent model (Shimotake et al., 2010). The most likely hypoth-
esis is that the “early” upregulation of VEGF (between 1 and 3 h
after MCAO) is associated with BBB permeability and contributes
to ischemic injury, while conversely, the neuroprotective effects
of VEGF, including neovascularization and neuronal protection,
occur in the days (48 h) after hypoxia (Marti et al., 2000).
EDEMA
One of the most important complications of TBI is edema,
which occurs more frequently in the pediatric than in the adult
population. This is possibly due to the higher water content
of the developing brain and also to the mechanism of regu-
lation of water homeostasis. There are few in vivo studies of
TBI and BBB disruption in neonates, with most focusing on
juvenile rodents. The Badault group has recently evaluated the
contribution of the aquaporins to the post-traumatic edema pro-
cess in juvenile rats and mice (Badaut et al., 2011a,b, 2014;
Fukuda et al., 2012, 2013). Pups treated with an inhibitor of
aquaporin-4, siGLO siAQP4, show acute improvements in motor
function (3 days after injury) and long-term improvements in
spatial memory (60 days after injury) when compared with con-
trol animals. These improvements are associated with decreased
edema formation, increased microglial activation, decreased BBB
disruption, and reduced astrogliosis and neuronal death. The
effectiveness of the treatment paradigm is associated with a
30% decrease in aquaporin-4 expression at the injection site.
Thus, aquaporin’s seems to be molecules significantly involved in
post-TBI damage, and represent an interesting therapeutic target
(Fukuda et al., 2013). Another study has revealed that the inhi-
bition of a kinase involved in the development of brain edema,
myosin light-chain kinase, by the administration of an inhibitor,
ML-7, to P24 mice starting 4 h after TBI and every 24 h until
sacrifice, significantly reduces BBB breakdown and the devel-
opment of cerebral edema, and preserves neurological function
(Rossi et al., 2013).
INFLAMMATORY RESPONSE
Neuroinflammation is a key pathological factor in most insults to
the developing brain (Degos et al., 2010a). Neuroinflammation is
induced by the invasion of pathogens or the release of damage-
associated proteins by injured and dying cells. Inflammation
includes the activation of microglia, astrocytes and endothe-
lial cells, leading to the secretion of proinflammatory cytokines
such as TNFα and IL-1β. There is an increased expression
of endothelial adhesion molecules such as vascular cell adhe-
sion molecule 1, intercellular adhesion molecule 1 and the
selectins (Simi et al., 2007). Inflammatory processes are, more-
over, associated with modifications of the molecular composi-
tion or functional state of TJs (Coisne and Engelhardt, 2011).
Proinflammatory cytokines also influence the expression of
MMPs, which increase BBB permeability by degrading TJs and
extracellular matrix components in the endothelial basement
membrane (Rosenberg, 2009). These events lead to barrier leak-
iness, which in turn allows pathogen and immune cell invasion
(Labus et al., 2014).
Resident microglia are some of the first cells to respond to
inflammatory stimuli. They canmigrate, together with astrocytes,
to the region of injury or infection, where they clean up cellular
debris and produce proinflammatory cytokines such as IL-1β and
IL-6. In the case of TBI and hypoxia-ischemia, mast cells also pro-
duce large quantities of proinflammatory mediators (Biran et al.,
2008; Jin et al., 2009).With regard to the BBB, these cytokines lead
to increased permeability and facilitate the entry of peripheral
macrophages and cytokines from the systemic circulation. In the
instance of inflammation following hypoxic-ischemic injury, this
has the effect of exacerbating the excitotoxic cascade by further
stimulating glutamate release and free radical and NO produc-
tion (McLean and Ferriero, 2004). The importance of the mast
cell response in causing brain damage after TBI is supported by
post-insult treatment with cromoglycate, a mast cell stabilizer
that inhibits mast cell degranulation and decreases BBB open-
ing (Strbian et al., 2006), glial activation and neuronal death (Jin
et al., 2007) sufficiently to provide long-term neuroprotection.
Leukocyte migration depends on strict interactions with
the vascular endothelium, mediated by 3 groups of adhesion
molecules: the selectins, the immunoglobulin superfamily (such
as intercellular adhesion molecule 1) and the integrins. The pat-
tern of recruitment of monocytes and macrophages is cytokine-
specific: IL-1β leads to neutrophil recruitment while TNFα
attracts monocytes (Blond et al., 2002). A comparative study in
P7 and adult rats subjected to transient middle cerebral artery
occlusion shows that Evans Blue extravasation, a measure of
paracellular diffusion, the main method of entry for bulky pro-
teins and leukocytes into the brain, remains low during the 24 h
period following reperfusion in neonatal rats but is profoundly
increased in adult rats. The largely unaltered paracellular diffu-
sion in neonatal rats is associated with the increased expression
of several TJ proteins (Vexler and Yenari, 2009) rather than with
the decrease in their expression seen in adult rats after a simi-
lar injury. In contrast to stroke in adults, in P7 hypoxic-ischemic
brains, the transmigration of neutrophils is far lower (Hudome
et al., 1997). This may be related to the greater resistance of
the BBB to hypoxia-ischemia-induced leaks at this age but also
to the immaturity of both endothelial cells, which express less
P-selectin (Lorant et al., 1999), and neutrophils, which are less
capable of adhering to P-selectin (Tcharmtchi et al., 2000). The
lower extent of leukocyte extravasation after ischemic injury in
neonatal rats may contribute to the age difference in the structural
and functional changes to the BBB after ischemia.
Specific studies have been carried out to examine the effects of
inflammation on the functions of the developing BBB and how
this influences the development of brain injury. A rather complex
and unexpected effect of inflammatory stimuli on BBB integrity
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and leukocyte transmigration has been reported during the first 3
weeks of life in rats. A comparison of the extent of IgG infiltration
in different brain regions following intrastriatal injections of IL-1
or TNFα in rats of different ages shows dramatically higher IgG
accumulation in 21-day-old than in 2-h-old rat pups (Anthony
et al., 1997, 1998; Schnell et al., 1999). These data demonstrate
that at birth, the BBB is functional, and is in fact more resistant to
inflammatory stress than in the juvenile brain.
Stolp et al. have conducted two studies of BBB behavior
in neonatal, juvenile and adult rats in response to prolonged
inflammatory stimuli, in particular the i.p. injection of 0.2mg/kg
lipopolysaccharide (LPS). They have demonstrated for the first
time a possible link between changes in BBB permeability (eval-
uated by permeability to sucrose, inulin and plasma proteins and
Cld-5 distribution) and behavioral alterations in animals exposed
to the inflammatory stimulus early in development, i.e., on post-
natal day (P) 0, P2, P4, P6, and P8. LPS treatment resulted
in increased permeability only in adulthood, preceded by Cld-
5 alterations in a few vessels at an earlier time point. However,
due to the normally low permeability of cerebral blood vessels,
it is probable that even a few vessels with altered permeabil-
ity could significantly contribute to the overall properties of the
BBB, and that these changes could explain the short-term changes
seen in behavioral tests, in particular in the prepulse inhibition
paradigm, that were distinguishable in juvenile animals but not
in adult animals. Long-term changes in permeability, as shown
by the sucrose permeability test, are correlated in adult rats with
altered responses to the dark/light test, suggesting that the impact
of inflammation could occur in several phases (short- and long-
term) and that each phase could lead to different behavioral
modifications (Stolp et al., 2005, 2011). A third study from the
same group analyzes, in a similar model (using the opossum
Monodelphis domestica), the ability of minocycline, a potent anti-
inflammatory molecule, to modulate the inflammation-induced
changes in BBB permeability and white matter damage follow-
ing acute and prolonged inflammation during development. The
effects of minocycline on inflammation were evaluated in terms of
IL-1βmRNA levels in the spleen and brain, and of white blood cell
counts in animals sacrificed 1.5 h after the first or fifth LPS injec-
tion (single or prolonged inflammatory stimuli). No differences
in IL-1β levels were seen between groups, although white blood
cells were significantly augmented in animals given prolonged
LPS stimulation compared to non-treated animals. Interestingly
minocycline significantly reduced this augmentation. The same
results were obtained if permeability to 14C-sucrose and plasma
proteins were evaluated: animals that received a single injection
of either LPS or LPS+minocycline showed no changes in BBB
permeability to 14C-sucrose or plasma proteins. Thus, the inclu-
sion of minocycline probably did not prevent barrier permeability
changes after a single LPS injection but prevented barrier per-
meability to proteins and 14C-sucrose when administered during
prolonged inflammation.
We have carried out further studies of the BBB in a model in
which inflammation alone induces WMD, by the twice-daily i.p.
injection of newborn rats or mice with IL-1 over 5 days (Favrais
et al., 2011). We evaluated modifications in the expression of the
most important choroid plexus TJ proteins at P2, the second
day of injections, and 5 days after the beginning of the injec-
tions (Favrais et al., 2011; Riddle et al., 2011; Schang et al., 2014).
Our results demonstrate that there is no significant non-specific
disruption of BCSFB integrity, as assessed by paracellular perme-
ability to tracers, and only a modest increase in Cld-3 expression
in the choroidal tissue. In adult animal models of inflammation,
the choroid plexus is known to be extremely sensitive to periph-
eral inflammatory stimuli, as demonstrated by the augmentation
of cytokines and other inflammatory markers (Quan et al., 1999;
Thibeault et al., 2001; Szmydynger-Chodobska et al., 2012), and
the choroid plexus-CSF system appears to be crucial for immune
cell trafficking into the CNS during neuroimmune surveillance as
well as in the early stages of neuroinflammatory diseases (Reboldi
et al., 2009; Schmitt et al., 2012). Thus, studies on the choroid
plexus conducted in the context of moderate systemic perinatal
inflammation occurring during a period approximating 28–35
weeks of gestation in humans, which alters the developmental
program of the white matter, should focus more on the perturba-
tion of specialized functions of the BCSFB, such as neuroimmune
regulation, rather than on gross non-specific alterations of barrier
integrity.
CONCLUSION
Inflammation, vascular reactivity and excitotoxicity are the main
protagonists of perinatal diseases, and the BBB and NVU are cer-
tainly majorly implicated in these processes. As our knowledge
of these processes increases, promising new targets for neuro-
protection have been found. However, a lot of questions remain
open, especially regarding differences between the behavior of
young and adult brains. In addition, even though clinical stud-
ies are impossible for obvious ethical reasons, the use of animal
models and/or in vitro studies impose great limitations in this
domain, since the therapeutic options validated in these mod-
els are not always as effective when applied to humans. Funding
research on the BBB, both in the pre-clinical and clinical domains,
should be encouraged in order to better understand early cerebral
development and develop effective therapeutic strategies.
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